Related Experiment Videos
Mapping genes controlling hematocrit in the spontaneously hypertensive rat
M Pravenec1, V Zidek, M Zdobinska
1Institute of Physiology, Academy of Sciences of the Czech Republic, Vídenská 1083, 142 20 Prague 4, Czech Republic.
Summary
Researchers identified genetic factors influencing hematocrit levels. The Eno2 gene marker on Chromosome 4 strongly correlates with hematocrit variation in rats, suggesting polygenic inheritance.
Area of Science:
- Genetics
- Physiology
- Animal Models
Background:
- Baseline hematocrit level determinants are largely unknown in humans and animals.
- The spontaneously hypertensive rat (SHR) model shows higher hematocrit than normotensive strains.
- Understanding hematocrit regulation is crucial for cardiovascular health research.
Purpose of the Study:
- To identify genes controlling baseline hematocrit levels.
- To investigate the genetic basis of increased hematocrit in spontaneously hypertensive rats (SHR).
- To analyze hematocrit variability in recombinant inbred (RI) strains derived from SHR and BN-Lx rats.
Main Methods:
- Comparative hematocrit analysis between SHR and Brown Norway (BN-Lx) rat strains.
- Hematocrit distribution analysis in recombinant inbred (RI) strains.
- Quantitative trait locus (QTL) mapping using genetic markers, including Eno2.
- Chromosomal mapping of the erythropoietin (Epo) gene.
Main Results:
- Hematocrit values in RI strains showed continuous distribution, indicating polygenic inheritance.
- The narrow heritability of hematocrit was estimated at 0.32.
- The Eno2 marker on Chromosome 4 exhibited the strongest association with hematocrit variability (p < 0.0001).
- The Epo gene was mapped to Chromosome 12, ruling it out as a candidate for increased SHR hematocrit.
Conclusions:
- Hematocrit regulation is a polygenic trait.
- The Eno2 gene region on Chromosome 4 is a significant locus associated with hematocrit variation.
- Linkage data contribute to understanding conserved chromosomal homologies across species.